Biotech company Bonti fetches $15.5 mln Series C
Newport Beach, California-based Bonti, a biotechnology company, has secured $15.5 million in Series C financing. City Hill Ventures led the round. In addition to the funding, Bonti has named David Ramsay as chief financial officer. Ramsay is the former CFO of Halozyme Therapeutics Inc.
24 January 2018•1 min read
